List of All Articles with Tag 'life'

About 15 miles south of Martha’s Vineyard, Massachusetts, a massive structure emerges from the Atlantic Ocean. Nearby it

If you love Uno, Mattel will pay you $277 an hour to play and promote their new game.

A new survey has found that nearly half of adults in the United States are interested in taking prescription drugs for weight loss, such as Ozempic or Wegovy. In a KFF health tracking poll published on 3 August, researchers reported that 45 per cent of adults said they’d be interested in taking a “safe and effective” prescription drug for weight loss. Meanwhile, seven in 10 adults said they’ve heard at least “a little” about a new class of drugs being used for weight loss, with about one in five saying they have heard “a lot” about these drugs. Ozempic is a type 2 diabetes medication known for its weight loss side effects. Similar semaglutide injections, such as Wegovy and Mounjaro, have been specifically approved for the treatment of obesity and weight loss. This class of drugs called GLP-1 agonists works by mimicking a hormone called glucagon-like peptide 1 (GLP-1), regulating blood sugar levels and slowing down the rate at which food leaves the stomach to create the feeling of fullness. Of the US adults surveyed, older groups were some of the most aware of prescription weight loss drugs, with 76 per cent being those who have been told by a doctor in the past five years that they are overweight or obese. Nearly 60 per cent of those surveyed said they were currently trying to lose weight as well. While there was an overall interest in taking a prescription weight loss drug, that interest significantly decreased when people were asked whether they would take the medication as a routine injection. Only 16 per cent of adults said they would still take Ozempic or Wegovy, even if it wasn’t covered by their health insurance and was not specifically approved by the US Food and Drug Administration for weight loss. In fact, most people believed that insurance companies should cover the cost of weight loss drugs for adults who are overweight or obese, with an overwhelming 80 per cent of adults. Additionally, a large majority of adults believed the substantial profits that pharmaceutical companies have made from increased demand for weight loss drugs is a major factor contributing to the cost of injections like Ozempic and Wegovy. According to Novo Nordisk, the pharmaceutical company behind these prescription drugs for diabetes and weight loss, the list price for Ozempic can cost $935.77 per month without health insurance. Although the majority of adults said they trust pharmaceutical companies like Novo Nordisk to provide “reliable information” about safety and side effects of GLP-1 agonists, only 22 per cent said they trust these companies to price their products fairly. The FDA has listed the most common side effects of taking Wegovy as nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, indigestion, dizziness, and digestive disorders. More serious complications can occur from use of Wegovy or Mounjaro, such as the “potential risk of thyroid C-cell tumours,” pancreatitis, gallbladder problems, acute kidney injury, increased heart rate, and suicidal behaviour or thinking. Taking Ozempic can also lead to possible thyroid tumours, including cancer, pancreatitis, changes in vision, and kidney and gallbladder problems. Recently, several patients reported suffering from severe gastroparesis, also known as stomach paralysis, after taking the prescription weight loss medications. In a report from CNN, two people claimed that their “stomachs are paralysed” after taking Ozempic. “I wish I never touched it. I wish I’d never heard of it in my life,” Joanie Knight, a 37-year-old from Louisiana, told CNN. “This medicine made my life hell. So much hell. It has cost me money. It cost me a lot of stress; it cost me days and nights and trips with my family. It’s cost me a lot, and it’s not worth it. The price is too high.” One woman was also diagnosed with cyclic vomiting syndrome, which causes her to throw up multiple times a day. “I’ve almost been off Ozempic for a year, but I’m still not back to my normal,” said Emily Wright, a 38-year-old teacher from Toronto. Shortly after the report, the FDA shared in a statement with The Independent that it has become aware of stomach paralysis occurring among patients taking the medications. “The FDA has received reports of gastroparesis with semaglutide and liraglutide, of which some documented the adverse event as not recovered after discontinuation of the respective product at the time of the report,” the agency said. However, officials clarified that they were unable to determine whether taking Ozempic or Wegovy was the cause of stomach paralysis, or if it was caused by a different issue. “Gastroparesis can be a complication of diabetes that is related to long-standing or poorly controlled disease, further complicating the ability to determine what role the drugs played in the reported events,” the FDA added. In response to reports of stomach paralysis, drug manufacturer Novo Nordisk noted that these medications have been used to treat type 2 diabetes “for more than 15 years”, and for the “treatment of obesity” for eight years. “Semaglutide has been extensively examined in robust clinical development programs, large real world evidence studies and has cumulatively over 9.5 million patient years of exposure,” a spokesperson for Novo Nordisk said in a statement to The Independent. “Gastrointestinal (GI) events are well-known side effects of the GLP-1 class. For semaglutide, the majority of GI side effects are mild to moderate in severity and of short duration. GLP-1’s are known to cause a delay in gastric emptying, as noted in the label of each of our GLP-1 RA medications. Symptoms of delayed gastric emptying, nausea and vomiting are listed as side effects.” Read More Obese people on weight-loss jabs ‘should be prepared to stay on them for life’ Ozempic users report stomach paralysis as weight loss drug side effect: ‘I wish I never touched it’ Sharon Osbourne says she was ‘nauseous’ for weeks after taking Ozempic to lose weight Sharon Osbourne reveals what Ozempic did to her when she was taking it Ozempic users report stomach paralysis as side effect: ‘I wish I never touched it’ Lorraine Candy: ‘Perimenopausal rage made me unravel’

August is peach season, and this cobbler is one of the simplest desserts to make with the stone fruit.

Mac Miller‘s estate has teamed up with Vans to create a pair of shoes in honour of the five-year anniversary of the rapper’s last album. The late rapper released his album Swimming on 3 August 2018. To celebrate the five-year anniversary of the album this year, Miller’s estate selected appropriate motifs based on both the late rapper’s style and what best represents him for a pair of Vans, one of his favourite sneaker brands. “A pair of black Vans Authentics - one of Malcolm’s favourite shoes, which he wore around the world many times over,” the estate’s Instagram announcement began. “Thanks to our friends at Vans for helping us create a special pair in celebration of the five-year anniversary of Swimming.” The shoes look similar to Vans classic black authentic shoes with a couple of extra details. They feature a yin-yang symbol in black and white with the words “Swimming by Mac Miller” surrounding them in a circle formation. Around the white trim towards the bottom of each shoe, it reads “Mac Miller 1992 to [infinity symbol]” to represent the scope and timelessness of Miller’s influence. Apart from the sentimental details, the shoes have their same original Vans logo on the heel of the sneaker and the iconic white laces. They will come in a pink and purple gradient box with “Swimming Mac Miller” stamped on the side, complete with the Vans logo next to another yin-yang symbol. The special collab can be found only be purchased on Mac Miller’s website, where the shoes will retail for $100. Part of the profit will go to the Mac Miller Fund, which is a part of the Pittsburgh Foundation. The fund is meant to support “young musicians with resources to help realise their full potential through exploration, expression and community,” per their website. Miller’s fifth and final album went on to debut at number three on the Billboard 200 upon release and entered the top 10 a second time one week after the late rapper’s death in 2018. It featured singles including “Self Care”, “What’s the Use?” and “Small Worlds”. Miller died from an accidental overdose on 7 September 2018, a little over a month after the release of Swimming. In 2019, the album was nominated for a Grammy in the Best Rap album category. The album lost to Cardi B’s Invasion of Privacy. One year later, Miller’s record label, Warner Music, released an album that the rapper was in the middle of recording called Circles, which was meant to be a companion album to Swimming. Together, they were supposed to fit the theme of swimming in circles. “He had been working with Jon Brion, who after hearing some early versions of songs cleared his calendar to help Malcolm fine-tune them,” a statement on the rapper’s Instagram read. “After his passing, Jon dedicated himself to finishing Circles based on his time and conversations with Malcolm.” Released in January 2020, the album featured the singles “Good Blues” and “New World.” Swimming was later certified platinum by the Recording Industry Association of America in 2021. Read More Angus Cloud gave final verdict on playing Mac Miller in biopic before his death Demi Lovato says she has ‘survivor’s guilt’ over Mac Miller’s death Mac Miller: Second drug supplier sentenced to 17 years in prison for giving rapper fentanyl-laced pills Vans and Mac Miller’s estate create shoes honouring late singer’s album anniversary Sweet moment UPS driver surprises his children after long week of deliveries Blackpink’s Jisoo confirmed to be dating K-drama actor Ahn Bo Hyun

Product kiosks are popping up at Costco locations, casting doubt over the role of human product demonstrators.

Lions Gate Entertainment Corp. has agreed to buy the EOne film and TV studio from toymaker Hasbro Inc.

Black parents and their children are more likely to experience unfair treatment when seeking medical care than others, a new study from the Urban Institute found.

Adidas has brought in $437 million from the first release of Yeezy sneakers left over after breaking ties with Ye, the rapper formerly known as Kanye West

Nintendo Co. hit a new high for first-quarter profit after the successful launch of its latest Legend of

Swiss inflation slowed to the lowest rate in one and a half years, testing the determination of Swiss

VIDANGOZ, Spain (AP) — A fine cloud of dust drifts across the sun-drenched landscape. The tinkling of sheep bells floats in the air, announcing the movement of 1,000 sheep and some goats through an ancient Spanish transhumance — or livestock migration — route.